Skip to content
Catalyst

esomeprazolePapers

Indexed under esomeprazole as a PubMed major topic

papers
14
7 years, by papers

Newest first

1 to 14 of 14

Every paper here, unless its row says otherwiseIndexed under esomeprazole in PubMed

  • Fourteen-and Ten-Day Tegoprazan-Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy for Helicobacter pylori Eradication-A Noninferiority, Multicenter, Randomized Controlled Trial.

    Journal of gastroenterology and hepatology2026PMID 41371765

  • Co-administration of calcium carbonate or sodium bicarbonate prevents esomeprazole-induced osteoporosis.

    Scientific reports2026PMID 42162236

  • REAL-WORLD EFFECTIVENESS OF HIGH-DOSE DUAL THERAPY VS OPTIMIZED CLARITHROMYCIN TRIPLE THERAPY FOR HELICOBACTER PYLORI: A PROSPECTIVE COHORT STUDY WITH TEST-OF-CURE SENSITIVITY ANALYSES.

    Arquivos de gastroenterologia2026PMID 42615755

  • Clinical Impact of High-dose Esomeprazole-amoxicillin Dual Therapy as Rescue Treatment for Helicobacter pylori Infection : A Prospective, Multicenter, Randomized Trial.

    Journal of clinical gastroenterology2025PMID 39495800

  • Concomitant use of clopidogrel and proton pump inhibitors: A retrospective analysis of prescription behaviour.

    British journal of clinical pharmacology2025PMID 39891382

  • A pilot study evaluating high dose esomeprazole, bismuth subcitrate and amoxicillin for eradicating Helicobacter pylori infection in Iran.

    Helicobacter2024PMID 38411303

  • Effectiveness of high-dose esomeprazole or pantoprazole 10-day sequential therapy empirically prescribed in Helicobacter pylori-infected naïve patients: a retrospective study.

    Journal of gastroenterology and hepatology2024PMID 39188083

  • Pharmacokinetics and Pharmacodynamics of a Fixed-Dose Combination of Esomeprazole and Magnesium Hydroxide Compared to the Enteric-Coated Esomeprazole.

    Clinical therapeutics2024PMID 39289057

  • Effectiveness and safety of vonoprazan and amoxicillin dual regimen with Saccharomyces boulardii supplements on eradication of Helicobacter pylori.

    BMC gastroenterology2024PMID 39592940

  • A Randomized, Double-Blind, Active-Control, Noninferiority, Multicenter, Phase 4 Study to Evaluate the Efficacy and Safety of Esomeprazole/Sodium Bicarbonate 20/800 mg in Patients with Nonerosive Gastroesophageal Reflux Disease.

    Gut and liver2023PMID 35730245

  • Time-dependent association between omeprazole and esomeprazole and hospitalization due to hyponatremia.

    European journal of clinical pharmacology2023PMID 36380227

  • Pharmacokinetics of Esomeprazole Magnesium After Single Oral Doses in Healthy Subjects: Bioequivalence Study and Food Effects.

    Clinical pharmacology in drug development2022PMID 35822412

  • Pharmacokinetics and Pharmacodynamics of Esomeprazole/Sodium Bicarbonate Immediate-Release Capsules in Healthy Chinese Volunteers: A Cross-Over, Randomized Controlled Trial.

    Advances in therapy2021PMID 33575950

  • A comparative study of 14-day dual therapy (esomeprazole and amoxicillin four times daily) and triple plus bismuth therapy for first-line Helicobacter pylori infection eradication: A randomized trial.

    Helicobacter2020PMID 33040439

Every paper about esomeprazole